Skip to main content
. 2021 Dec 13;12:781789. doi: 10.3389/fphys.2021.781789

FIGURE 1.

FIGURE 1

Both FLI and serum FABP4 levels are increased in metabolic patients. FLI (A) and serum FABP4 levels (B) in diabetic (DM), obese (OB) and metabolic syndrome (MS) patients. Black bars correspond to metabolic patients and white bars to non-metabolic individuals. Data are expressed as the means ± SEM. **P < 0.01, ***P < 0.001 vs control non-metabolic patients.